Changes in renal function associated with indinavir

AIDS

Volumn 12, Issue 18, 1998, Pages

  Boubaker, Karim ^a   Sudre, Philippe ^b   Bally, Frank ^a   Vogel, Gerard ^a   Meuwly, Jean Yves ^a   Glauser, Michel P ^a   Telenti, Amalio ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Swiss HIV Cohort Study Data Center   (Switzerland)

Author keywords

Crystalluria; Leukocyturia; Nephropathy; Protease inhibitor; Renal colic; Toxicity

Indexed keywords

INDINAVIR; NELFINAVIR; RITONAVIR;

ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYSTALLURIA; DYSURIA; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY COLIC; KIDNEY FUNCTION; LEUKOCYTURIA; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PAIN; PRIORITY JOURNAL;

EID: 0032564632     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199818000-00003     Document Type: Article

References (14)

1. Finzi D, Hermankova M, Pierson I, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
2. Wong JK, Hezareh M, Günthard HF, et al.: Recovery of replication-competent HIV despite prolonged suppression of plasma viraemia. Science 1997, 278:1291-1295.
3. Chun TW, Stuyver L, Mizell SB, et al.: Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 1997, 94:13193-13197.
4. Kopp JB, Miller KD, Micanet JAM, et al.: Cryslalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 1997, 127:119-125.
5. Sutherland SE, Reigle MD, Seítel AD, Resnick MI: Protease inhibitors and urolithiasis. J Urol 1997, 158:31-33.
6. Valencia ME, Jiménez-Nacher I, Rodriguez-Rosado R, Soriano V, Carrillo de Albornoz ML, Gonzalez Lahoz J: Incidence of nephrolithiasis in HIV infected patients under indinavir treatment. Sixth European Conference on Clinical Aspects and Treatment of HIV Infection. Hamburg, October 1997 [abstract 448].
7. Tubiana R, Bochet MV, Martinez F, Guery B, Katlama C, Deray G: Renal tolerante of indinavir in HIV-1 infected patients Sixth European Conference on Clinical Aspects and Treatment of HIV Infection. Hamburg, October 1997 [abstract 446].
8. Sarcletti M, Petter A, Thotta K, Konig P, Zangerle R: Increase risk of indinavir nephropathy in women. Fifth Conference on Retroviruses and Opportunistic Infections. Chicago, February 1998 [abstract 418].
9. Hammer SM, Squires KE, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell count of 200 per millimetre or less. N Engl J Med 1997, 337:725-733.
10. Rao TK: Renal complications in HIV disease. Med Clin North Am 1996, 80:1437-1451.
11. Tashima KT, Horowitz JD, Rosen S: Indinavir nephropathy. N Engl J Med 1997, 336:138-139.
12. Martinez F, Mommeja-Marin H, Estepa-Maurice L, et al.: Indinavir crystals deposits associated with tubulointerstitial nephropathy. Nephrol Dial Transplant 1998, 13:750-753.
13. Witte M, Tobon A, Gruenenfelder J, Goldfarb R, Coburn M: Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis. J Urol 1998, 159:498-499.
14. Chen SCA, Nankivell BJ, Dwyer DE: Indinavir-induced renal failure [letter]. AIDS 1998, 12:440-441.